Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$17.5 - $25.9 $249,200 - $368,816
-14,240 Reduced 47.02%
16,042 $415,000
Q4 2022

Feb 14, 2023

BUY
$13.95 - $19.28 $13,796 - $19,067
989 Added 3.38%
30,282 $543,000
Q3 2022

Nov 14, 2022

BUY
$14.66 - $18.3 $429,435 - $536,061
29,293 New
29,293 $496,000
Q3 2022

Nov 14, 2022

BUY
$14.66 - $18.3 $429,435 - $536,061
29,293 New
29,293 $496,000
Q2 2022

Aug 15, 2022

SELL
$14.1 - $20.26 $166,760 - $239,615
-11,827 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$15.23 - $21.47 $180,125 - $253,925
11,827 New
11,827 $238,000
Q4 2021

Feb 14, 2022

SELL
$21.65 - $27.0 $720,923 - $899,073
-33,299 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$19.51 - $28.7 $649,663 - $955,681
33,299 New
33,299 $843,000

Others Institutions Holding STVN

About Stevanato Group S.p.A.


  • Ticker STVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 264,700,000
  • Market Cap $5.44B
  • Description
  • Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machine...
More about STVN
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.